6810
新穎生醫
0.00 (0.00%)21.0112成交張數–本益比–股價淨值比–殖利率2026-09-08資料日期
月營收
柱為單月營收(億元),線為年增率;近十年
| 月份 | 營收(億) | 月增 | 年增 | 去年同月(億) | 累計營收(億) | 累計年增 |
|---|---|---|---|---|---|---|
| 2026/08 | 0.01 | 169.5% | 232.0% | 0.00 | 0.02 | 54.9% |
| 2026/07 | 0.00 | 35.8% | -16.4% | 0.00 | 0.02 | 29.0% |
| 2026/06 | 0.00 | -56.2% | -15.8% | 0.00 | 0.01 | 41.5% |
| 2026/05 | 0.00 | 87.9% | 89.6% | 0.00 | 0.01 | 56.0% |
| 2026/04 | 0.00 | -24.9% | 1.9% | 0.00 | 0.01 | 44.4% |
| 2026/03 | 0.00 | 71.7% | 44.7% | 0.00 | 0.01 | 66.3% |
| 2026/02 | 0.00 | -27.5% | 24.8% | 0.00 | 0.00 | 86.3% |
| 2026/01 | 0.00 | -41.9% | 189.9% | 0.00 | 0.00 | 189.9% |
| 2025/12 | 0.00 | 60.2% | 245.6% | 0.00 | 0.03 | -78.6% |
| 2025/11 | 0.00 | -6.8% | -97.4% | 0.10 | 0.02 | -81.7% |
| 2025/10 | 0.00 | 30.0% | 3.5% | 0.00 | 0.02 | -22.2% |
| 2025/09 | 0.00 | 4.6% | 43.0% | 0.00 | 0.02 | -25.1% |
| 2025/08 | 0.00 | -32.2% | 21.3% | 0.00 | 0.02 | -29.6% |
| 2025/07 | 0.00 | 36.8% | -10.6% | 0.00 | 0.01 | -33.6% |
| 2025/06 | 0.00 | -1.4% | -45.1% | 0.00 | 0.01 | -38.0% |
| 2025/05 | 0.00 | 1.0% | -48.4% | 0.00 | 0.01 | -35.9% |
| 2025/04 | 0.00 | 6.6% | -52.2% | 0.00 | 0.01 | -30.1% |
| 2025/03 | 0.00 | 48.1% | 51.5% | 0.00 | 0.00 | -8.5% |
| 2025/02 | 0.00 | 68.4% | 2.3% | 0.00 | 0.00 | -33.1% |
| 2025/01 | 0.00 | -30.7% | -57.8% | 0.00 | 0.00 | -57.8% |
| 2024/12 | 0.00 | -98.8% | 776.9% | 0.00 | 0.12 | 918.0% |
| 2024/11 | 0.10 | 3675.7% | – | 0.00 | 0.12 | 919.5% |
| 2024/10 | 0.00 | 79.6% | 112.5% | 0.00 | 0.03 | 113.8% |
| 2024/09 | 0.00 | -11.3% | 13.6% | 0.00 | 0.02 | 114.0% |
| 2024/08 | 0.00 | -50.0% | 34.5% | 0.00 | 0.02 | 127.2% |
| 2024/07 | 0.00 | -16.0% | 188.3% | 0.00 | 0.02 | 140.4% |
| 2024/06 | 0.00 | -7.3% | 318.7% | 0.00 | 0.02 | 133.1% |
| 2024/05 | 0.00 | -6.4% | 38.4% | 0.00 | 0.01 | 106.2% |
| 2024/04 | 0.00 | 237.7% | 183.2% | 0.00 | 0.01 | 166.9% |
| 2024/03 | 0.00 | 0.0% | 1525.0% | 0.00 | 0.00 | 152.5% |
| 2024/02 | 0.00 | -30.5% | 1.6% | 0.00 | 0.00 | 87.6% |
| 2024/01 | 0.00 | 1338.5% | 356.1% | 0.00 | 0.00 | 356.1% |
| 2023/12 | 0.00 | – | -93.2% | 0.00 | 0.01 | -44.5% |
| 2023/11 | 0.00 | -100.0% | -100.0% | 0.00 | 0.01 | -39.8% |
| 2023/10 | 0.00 | -4.0% | -23.6% | 0.00 | 0.01 | -39.3% |
| 2023/09 | 0.00 | 5.0% | -7.4% | 0.00 | 0.01 | -40.7% |
| 2023/08 | 0.00 | 7.2% | 10.2% | 0.00 | 0.01 | -43.4% |
| 2023/07 | 0.00 | 22.0% | -78.5% | 0.01 | 0.01 | -47.0% |
| 2023/06 | 0.00 | -69.4% | -79.8% | 0.00 | 0.01 | -31.6% |
| 2023/05 | 0.00 | 91.6% | 253.6% | 0.00 | 0.01 | 4.7% |
| 2023/04 | 0.00 | 1837.5% | 1837.5% | 0.00 | 0.00 | -35.8% |
| 2023/03 | 0.00 | -93.8% | 166.7% | 0.00 | 0.00 | -65.2% |
| 2023/02 | 0.00 | 212.2% | 88.2% | 0.00 | 0.00 | -66.6% |
| 2023/01 | 0.00 | -78.5% | -90.6% | 0.00 | 0.00 | -90.6% |
| 2022/12 | 0.00 | 1023.5% | 36.4% | 0.00 | 0.02 | 149.7% |
| 2022/11 | 0.00 | -89.2% | -96.1% | 0.00 | 0.02 | 171.3% |
| 2022/10 | 0.00 | 16.3% | -28.3% | 0.00 | 0.02 | 569.7% |
| 2022/09 | 0.00 | 25.0% | – | 0.00 | 0.02 | 2316.0% |
| 2022/08 | 0.00 | -79.1% | 44.0% | 0.00 | 0.02 | 2136.0% |
| 2022/07 | 0.01 | 14.6% | – | 0.00 | 0.02 | – |
| 2022/06 | 0.00 | 436.9% | – | 0.00 | 0.01 | – |
| 2022/05 | 0.00 | 950.0% | – | 0.00 | 0.01 | – |
| 2022/04 | 0.00 | 166.7% | – | 0.00 | 0.01 | – |
| 2022/03 | 0.00 | -95.6% | – | 0.00 | 0.01 | – |
| 2022/02 | 0.00 | -84.5% | – | 0.00 | 0.01 | – |
| 2022/01 | 0.00 | 212.9% | – | 0.00 | 0.00 | – |
| 2021/12 | 0.00 | -68.0% | – | 0.00 | 0.01 | – |
| 2021/11 | 0.00 | 100.0% | – | 0.00 | 0.01 | – |
| 2021/10 | 0.00 | – | – | 0.00 | 0.00 | – |
| 2021/09 | 0.00 | – | – | 0.00 | 0.00 | – |